Nuveen LLC purchased a new stake in TrueBlue, Inc. (NYSE:TBI - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 735,820 shares of the business services provider's stock, valued at approximately $3,907,000. Nuveen LLC owned approximately 2.46% of TrueBlue at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of TBI. GAMMA Investing LLC boosted its stake in TrueBlue by 217.2% in the 1st quarter. GAMMA Investing LLC now owns 8,135 shares of the business services provider's stock valued at $43,000 after buying an additional 5,570 shares in the last quarter. XTX Topco Ltd acquired a new stake in TrueBlue in the 1st quarter valued at $86,000. AE Wealth Management LLC boosted its stake in TrueBlue by 55.2% in the 1st quarter. AE Wealth Management LLC now owns 19,616 shares of the business services provider's stock valued at $104,000 after buying an additional 6,973 shares in the last quarter. MetLife Investment Management LLC boosted its stake in TrueBlue by 23.5% in the 4th quarter. MetLife Investment Management LLC now owns 15,886 shares of the business services provider's stock valued at $133,000 after buying an additional 3,028 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its stake in TrueBlue by 24.7% in the 4th quarter. Wells Fargo & Company MN now owns 17,112 shares of the business services provider's stock valued at $144,000 after buying an additional 3,393 shares in the last quarter. Institutional investors and hedge funds own 97.15% of the company's stock.
TrueBlue Trading Down 0.4%
Shares of TBI traded down $0.03 during trading hours on Tuesday, hitting $5.95. 132,815 shares of the stock traded hands, compared to its average volume of 170,120. The company has a current ratio of 1.94, a quick ratio of 1.94 and a debt-to-equity ratio of 0.18. TrueBlue, Inc. has a 1-year low of $3.45 and a 1-year high of $9.05. The firm has a market capitalization of $177.76 million, a PE ratio of -5.17 and a beta of 1.54. The business has a fifty day moving average of $6.45 and a 200-day moving average of $5.85.
TrueBlue (NYSE:TBI - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The business services provider reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.31) by $0.24. TrueBlue had a negative return on equity of 5.74% and a negative net margin of 2.21%.The business had revenue of $396.30 million for the quarter, compared to analyst estimates of $400.52 million. TrueBlue has set its Q3 2025 guidance at EPS. Analysts expect that TrueBlue, Inc. will post 0.15 EPS for the current year.
Wall Street Analyst Weigh In
Separately, BMO Capital Markets boosted their price target on TrueBlue from $7.00 to $8.00 and gave the company an "outperform" rating in a research note on Wednesday, August 6th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $8.00.
Check Out Our Latest Analysis on TBI
About TrueBlue
(
Free Report)
TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.
Further Reading

Before you consider TrueBlue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TrueBlue wasn't on the list.
While TrueBlue currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.